These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37014039)

  • 1. Matched Molecular Pair Analysis in Drug Discovery: Methods and Recent Applications.
    Yang Z; Shi S; Fu L; Lu A; Hou T; Cao D
    J Med Chem; 2023 Apr; 66(7):4361-4377. PubMed ID: 37014039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR-assisted-MMPA to expand chemical transformation space for lead optimization.
    Fu L; Yang ZY; Yang ZJ; Yin MZ; Lu AP; Chen X; Liu S; Hou TJ; Cao DS
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33418563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semi-automated workflow for molecular pair analysis and QSAR-assisted transformation space expansion.
    Yang ZY; Fu L; Lu AP; Liu S; Hou TJ; Cao DS
    J Cheminform; 2021 Nov; 13(1):86. PubMed ID: 34774096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matched molecular pair analysis in drug discovery.
    Dossetter AG; Griffen EJ; Leach AG
    Drug Discov Today; 2013 Aug; 18(15-16):724-31. PubMed ID: 23557664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matched molecular pair analysis: significance and the impact of experimental uncertainty.
    Kramer C; Fuchs JE; Whitebread S; Gedeck P; Liedl KR
    J Med Chem; 2014 May; 57(9):3786-802. PubMed ID: 24738976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-Silico Extraction of Design Ideas Using MMPA-by-QSAR and its Application on ADME Endpoints.
    Koutsoukas A; Chang G; Keefer CE
    J Chem Inf Model; 2019 Jan; 59(1):477-485. PubMed ID: 30497262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graph neural networks for automated de novo drug design.
    Xiong J; Xiong Z; Chen K; Jiang H; Zheng M
    Drug Discov Today; 2021 Jun; 26(6):1382-1393. PubMed ID: 33609779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mmpdb: An Open-Source Matched Molecular Pair Platform for Large Multiproperty Data Sets.
    Dalke A; Hert J; Kramer C
    J Chem Inf Model; 2018 May; 58(5):902-910. PubMed ID: 29770697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular design in drug discovery: a comprehensive review of deep generative models.
    Cheng Y; Gong Y; Liu Y; Song B; Zou Q
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34415297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of compound properties, multiparameter optimization, and computational drug design methods for PARP-1 inhibitor drugs.
    Hirlekar BU; Nuthi A; Singh KD; Murty US; Dixit VA
    Eur J Med Chem; 2023 Apr; 252():115300. PubMed ID: 36989813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the design and discovery of synthetic tyrosinase inhibitors.
    Li J; Feng L; Liu L; Wang F; Ouyang L; Zhang L; Hu X; Wang G
    Eur J Med Chem; 2021 Nov; 224():113744. PubMed ID: 34365131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacophore modeling and applications in drug discovery: challenges and recent advances.
    Yang SY
    Drug Discov Today; 2010 Jun; 15(11-12):444-50. PubMed ID: 20362693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graph mining: procedure, application to drug discovery and recent advances.
    Takigawa I; Mamitsuka H
    Drug Discov Today; 2013 Jan; 18(1-2):50-7. PubMed ID: 22889967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cheminformatics in Drug Discovery, an Industrial Perspective.
    Chen H; Kogej T; Engkvist O
    Mol Inform; 2018 Sep; 37(9-10):e1800041. PubMed ID: 29774657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Prediction of Antitarget Activity by Matched Molecular Pairs Analysis.
    Warner DJ; Bridgland-Taylor MH; Sefton CE; Wood DJ
    Mol Inform; 2012 May; 31(5):365-8. PubMed ID: 27477265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based drug design with geometric deep learning.
    Isert C; Atz K; Schneider G
    Curr Opin Struct Biol; 2023 Apr; 79():102548. PubMed ID: 36842415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review.
    Tripathi N; Goshisht MK; Sahu SK; Arora C
    Mol Divers; 2021 Aug; 25(3):1643-1664. PubMed ID: 34110579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemistry-driven Hit-to-lead Optimization Guided by Structure-based Approaches.
    Hoffer L; Muller C; Roche P; Morelli X
    Mol Inform; 2018 Sep; 37(9-10):e1800059. PubMed ID: 30051601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaching Target Selectivity by De Novo Drug Design.
    Fischer T; Gazzola S; Riedl R
    Expert Opin Drug Discov; 2019 Aug; 14(8):791-803. PubMed ID: 31179763
    [No Abstract]   [Full Text] [Related]  

  • 20. Design of bivalent ligands targeting putative GPCR dimers.
    Huang B; St Onge CM; Ma H; Zhang Y
    Drug Discov Today; 2021 Jan; 26(1):189-199. PubMed ID: 33075471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.